PBBM Considerations for Base Models, Model Validation, and Application Steps: Workshop Summary Report.
- DOI
- 10.1021/acs.molpharmaceut.4c00758
- Published
- 2024 Nov 4
- Container
- Molecular pharmaceutics
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1021/acs.molpharmaceut.4c00758,
title = {PBBM Considerations for Base Models, Model Validation, and Application Steps: Workshop Summary Report.},
author = {Heimbach T and Musuamba Tshinanu F and Raines K and Borges L and Kijima S and Malamatari M and Moody R and Veerasingham S and Seo P and Turner D and Fang L and Stillhart C and Bransford P and Ren X and Patel N and Sperry D and Chen H and Rostami-Hodjegan A and Lukacova V and Sun D and Nguefack JF and Carducci T and Grimstein M and Pepin X and Jamei M and Stamatopoulos K and Li M and Sanghavi M and Tannergren C and Mandula H and Zhao Z and Ju TR and Wagner C and Arora S and Wang M and Rullo G and Mitra A and Kollipara S and Chirumamilla SK and Polli JE and Mackie C},
year = {2024},
journal = {Molecular pharmaceutics},
doi = {10.1021/acs.molpharmaceut.4c00758},
url = {https://doi.org/10.1021/acs.molpharmaceut.4c00758}
}RIS
TY - JOUR TI - PBBM Considerations for Base Models, Model Validation, and Application Steps: Workshop Summary Report. AU - Heimbach T AU - Musuamba Tshinanu F AU - Raines K AU - Borges L AU - Kijima S AU - Malamatari M AU - Moody R AU - Veerasingham S AU - Seo P AU - Turner D AU - Fang L AU - Stillhart C AU - Bransford P AU - Ren X AU - Patel N AU - Sperry D AU - Chen H AU - Rostami-Hodjegan A AU - Lukacova V AU - Sun D AU - Nguefack JF AU - Carducci T AU - Grimstein M AU - Pepin X AU - Jamei M AU - Stamatopoulos K AU - Li M AU - Sanghavi M AU - Tannergren C AU - Mandula H AU - Zhao Z AU - Ju TR AU - Wagner C AU - Arora S AU - Wang M AU - Rullo G AU - Mitra A AU - Kollipara S AU - Chirumamilla SK AU - Polli JE AU - Mackie C PY - 2024 JO - Molecular pharmaceutics DO - 10.1021/acs.molpharmaceut.4c00758 UR - https://doi.org/10.1021/acs.molpharmaceut.4c00758 ER -
APA
T, H., F, M. T., K, R., L, B., S, K., M, M., R, M., S, V., P, S., D, T., L, F., C, S., P, B., X, R., N, P., D, S., H, C., A, R., V, L., D, S., JF, N., T, C., M, G., X, P., M, J., K, S., M, L., M, S., C, T., H, M., Z, Z., TR, J., C, W., S, A., M, W., G, R., A, M., S, K., SK, C., JE, P., & C, M. (2024). PBBM Considerations for Base Models, Model Validation, and Application Steps: Workshop Summary Report.. Molecular pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.4c00758
Source records
- pubmed · retrieved 2026-09-25T17:30:35.969Z